CATALYST PHARMACEUTICALS INC

CPRX09 Dec 2024
Healthcare
$22.12
-0.01 (-0.61%)
Lowest Today
$21.77
Highest Today
$22.31
Today’s Open
$22.12
Prev. Close
$22.02
52 Week High
$24.27
52 Week Low
$13
To Invest in CATALYST PHARMACEUTICALS INC

CATALYST PHARMACEUTICALS INC

Healthcare
CPRX09 Dec 2024
-0.01 (-0.61%)
1M
3M
6M
1Y
5Y
Low
$21.77
Day’s Range
High
$22.31
21.77
52 Week Low
$13
52-Week Range
52 Week High
$24.27
13
1 Day
-
1 Week
-2.19%
1 month return
-7.9%
3 month return
+12.08%
6 month return
+41%
1 Year return
+55.76%
3 Years return
+218.74%
5 Years return
+388.9%
10 Years return
-
Institutional Holdings
BlackRock Inc
15.67
Vanguard Group Inc
6.74
iShares Core S&P Small-Cap ETF
6.04
Deerfield Management Co
5.22
State Street Corp
4.77
Vanguard Total Stock Mkt Idx Inv
2.96
iShares Russell 2000 ETF
2.6

Market Status

Fundamentals
Market Cap
2626.39 mln
PB Ratio
3.92
PE Ratio
18.35
Enterprise Value
2149.18 mln
Total Assets
470.11 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Organisation
CATALYST PHARMACEUTICALS INC
Employees
167
Industry
Biotechnology
CEO
Mr. Richard John  Daly M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step